Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06XVF
|
||||
| Former ID |
DCL001106
|
||||
| Drug Name |
CBT-1
|
||||
| Indication | Non-small cell lung cancer [ICD10:C33-C34] | Phase 3 | [521968] | ||
| Company |
National Institutes of Health Clinical Center (CC)
|
||||
| Target and Pathway | |||||
| Target(s) | Multidrug resistance protein 1 | Target Info | Modulator | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
| References | |||||